C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance
Public ClinicalTrials.gov record NCT00589355. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this study is to determine whether markers of vascular inflammation (such as c-reactive protein) can predict endothelial dysfunction (as measured by flow-mediated dilation) in postmenopausal women with glucose intolerance compared to normal controls.
Study identification
- NCT ID
- NCT00589355
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 46 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 40 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2001
- Primary completion
- May 31, 2003
- Completion
- Sep 30, 2008
- Last update posted
- Apr 16, 2020
2002 – 2008
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yale Center for Clinical Investigation | New Haven | Connecticut | 06520 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Glucose Intolerance trials
Other public records listing Glucose Intolerance. Sorted by last update posted; newest first. Not a recommendation.
- NCT04737200: The Impact of Overnight Nutrition Support on Sleep and Circadian Rhythm Disruption in the ICU Recruiting
- NCT05874635: Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) Active, not recruiting
- NCT05121844: Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform Active, not recruiting
- NCT06366399: The Acute T-Rex (Timing of Resistance Exercise) Study Recruiting
- NCT05468255: The Impact of Removal of Exercise on Glycemic Control and Vascular Health in Older Active Adults Recruiting
- NCT05775627: Sleep and Metabolism Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00589355, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2020 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00589355 live on ClinicalTrials.gov.